Forza Innovations

Forza Innovations SGA/Revenue

The SGA to Revenue Ratio of Forza Innovations (FORZ) as of Nov 10, 2026 is 857.75 %. In the previous year, SGA to Revenue Ratio was 885.16 % — a change of -3.10% (lower).

SGA/Revenue

857.75 %

YoY

-3.10%

Last updated:

SGA to Revenue Ratio of Forza Innovations is 2024 857.75 % . SGA to Revenue Ratio of Forza Innovations was 2023 885.16 % . It decreases by -3.10% lower compared to the previous year.

The Forza Innovations SGA/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

SGA/Revenue
Date
SGA/Revenue
Jan 1, 2017
3.54 M USD
Jan 1, 2018
93.24 USD
Jan 1, 2019
19.29 USD
Jan 1, 2020
38.27 USD
Jan 1, 2021
9.94 USD
Jan 1, 2022
7,000.97 USD
Jan 1, 2023
885.16 USD
Jan 1, 2024
857.75 USD
The Forza Innovations SGA/Revenue history
YEARSGA/RevenueYoY
857.75 %-3.10%
885.16 %-87.36%
7,000.97 %+70,349.90%
9.94 %-74.04%
38.27 %+98.40%
19.29 %-79.31%
93.24 %-100.00%
3.54 M %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Forza Innovations Stock analysis

What does Forza Innovations do? Forza Innovations, Inc. generates revenue through the sale of its WarmUp product line, which includes the J4 Sport, J4 X, and J4 Fitbelt wearable back compression devices. These devices utilize carbon microfibers and rechargeable lithium batteries to provide therapeutic heat application, targeting stiff and sore muscles. The J4 Sport is designed for patients with chronic conditions like arthritis, osteoporosis, fibromyalgia, and ligament strains, while the J4 Fitbelt focuses on abdominal and lower back muscles or single muscle groups. The J4 Core supports users during physical activities, recovery, and daily routines. The company's revenue streams are derived from direct sales of these therapeutic wearable devices to consumers seeking relief from muscle stiffness and inflammation. The WarmUp series targets health-conscious individuals and patients managing chronic pain conditions, positioning itself as a solution for both active lifestyles and medical needs. Products are sold under the WarmUp brand, with specific models catering to distinct user segments based on their therapeutic requirements. Forza Innovations has acquired ownership of late developmental stage products, including the WarmUp line, which are now its primary revenue-generating assets. The company focuses on the health-tech wearable performance market, emphasizing the therapeutic benefits of heat application through its carbon microfiber technology. Sales are driven by the specific medical and wellness applications of each product model. Forza Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Forza Innovations stock

SGA to Revenue Ratio of Forza Innovations is 857.75 % in 2024.

SGA to Revenue Ratio of Forza Innovations changed from 885.16 % to 857.75 %, representing a -3.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of SGA to Revenue Ratio Forza Innovations since 2006 – with annual values, charts, and detailed analysis.

The SGA/Revenue ratio shows what percentage of revenue is consumed by selling, general, and administrative costs. Lower ratios indicate greater operating efficiency.

A 'good' varies by industry and company stage. On Eulerpool, you can compare SGA to Revenue Ratio's Forza Innovations with sector peers and the industry average to assess whether it is attractive.

To evaluate SGA to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for SGA to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Forza Innovations

All Key Metrics — Forza Innovations